Surgepays Inc (NASDAQ: SURG)’s Stock Is Up 35.12%, A Prediction For What Could Come Next

During the last session, Surgepays Inc (NASDAQ:SURG)’s traded shares were 0.48 million, with the beta value of the company hitting 1.38. At the end of the trading day, the stock’s price was $2.05, reflecting an intraday gain of 14.53% or $0.26. The 52-week high for the SURG share is $9.23, that puts it down -350.24 from that peak though still a striking 35.12% gain since the share price plummeted to a 52-week low of $1.33. The company’s market capitalization is $40.47M, and the average intraday trading volume over the past 10 days was 0.11 million shares, and the average trade volume was 172.51K shares over the past three months.

Surgepays Inc (SURG) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 2.00. SURG has a Sell rating from 0 analyst(s) out of 2 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 2 recommend a Buy rating for it.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Surgepays Inc (NASDAQ:SURG) trade information

Surgepays Inc (SURG) registered a 14.53% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 14.53% in intraday trading to $2.05, hitting a weekly high. The stock’s 5-day price performance is 15.17%, and it has moved by 39.46% in 30 days. Based on these gigs, the overall price performance for the year is -55.53%. The short interest in Surgepays Inc (NASDAQ:SURG) is 0.4 million shares and it means that shorts have 2.83 day(s) to cover.

The consensus price target of analysts on Wall Street is $10, which implies an increase of 79.5% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $10 and $10 respectively. As a result, SURG is trading at a discount of -387.8% off the target high and -387.8% off the low.

Surgepays Inc (SURG) estimates and forecasts

Statistics show that Surgepays Inc has underperformed its competitors in share price, compared to the industry in which it operates. Surgepays Inc (SURG) shares have gone down -48.23% during the last six months, with a year-to-date growth rate less than the industry average at -174.64% against 18.70.

While earnings are projected to return -180.19% in 2024, the next five years will return 15.00% per annum.

SURG Dividends

Surgepays Inc is due to release its next quarterly earnings on 2024-Nov-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Surgepays Inc (NASDAQ:SURG)’s Major holders

Surgepays Inc insiders own 31.94% of total outstanding shares while institutional holders control 9.47%, with the float percentage being 13.91%. VANGUARD GROUP INC is the largest shareholder of the company, while 44.0 institutions own stock in it. As of 2024-06-30, the company held over 0.53 million shares (or 3.0031% of all shares), a total value of $1.7 million in shares.

The next largest institutional holding, with 0.4 million shares, is of CABLE CAR CAPITAL LLC’s that is approximately 2.2607% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $1.28 million.